Discovery of a novel and potent, and urea isostere inhibitors series of dianilinopyrimidineurea of VEGFR2 tyrosine kinase

被引：33

作者：

Sammond, DM ^{[1
]}

Nallor, KE ^{[1
]}

Veal, JM ^{[1
]}

Nolte, RT ^{[1
]}

Wang, LP ^{[1
]}

Knick, VB ^{[1
]}

Rudolph, SK ^{[1
]}

Truesdale, AT ^{[1
]}

Nartey, EN ^{[1
]}

Stafford, JA ^{[1
]}

Kumar, R ^{[1
]}

Cheung, M ^{[1
]}

机构：

[1] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 15期

关键词：

VEGFR2; FLK-1; KDR; kinase inhibitor;

D O I：

10.1016/j.bmcl.2005.05.096

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：3519 / 3523

页数：5

共 50 条

[41] Expression of receptor tyrosine kinase targets PDGFR-, VEGFR2 and KIT in canine transitional cell carcinoma
Walters, L.
Martin, O.
Price, J.
Sula, M. M.
VETERINARY AND COMPARATIVE ONCOLOGY, 2018, 16 (01) : E117 - E122
[42] Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitors
Wurz, Ryan P.
Sastri, Christine
D'Amico, Derin C.
Herberich, Brad
Jackson, Claire L. M.
Pettus, Liping H.
Tasker, Andrew S.
Wu, Bin
Guerrero, Nadia
Lipford, J. Russell
Winston, Jeffrey T.
Yang, Yajing
Wang, Paul
Nguyen, Yen
Andrews, Kristin L.
Huang, Xin
Lee, Matthew R.
Mohr, Christopher
Zhang, J. D.
Reid, Darren L.
Xu, Yang
Zhou, Yihong
Wang, Hui-Ling
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (22) : 5580 - 5590
[43] Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase
Porter, John
Lumb, Simon
Lecomte, Fabien
Reuberson, James
Foley, Anne
Calmiano, Mark
le Riche, Kelly
Edwards, Helen
Delgado, Jean
Franklin, Richard J.
Gascon-Simorte, Jose M.
Maloney, Alison
Meier, Christoph
Batchelor, Mark
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (02) : 397 - 400
[44] Scaffold hopping and redesign approaches for quinazoline based urea derivatives as potent VEGFR-2 inhibitors
Hadi, Soha R. Abd El
Lasheen, Deena S.
Soliman, Dalia H.
Elrazaz, Eman Z.
Abouzid, Khaled A. M.
BIOORGANIC CHEMISTRY, 2020, 101
[45] New 2-oxoindole derivatives as multiple PDGFRα/ß and VEGFR-2 tyrosine kinase inhibitors
Ezelarab, Hend A. A.
El-Hafeez, Amer Ali Abd
Ali, Taha F. S.
Sayed, Ahmed M.
Hassan, Heba A.
Beshr, Eman A. M.
Abbas, Samar H.
BIOORGANIC CHEMISTRY, 2024, 145
[46] Core Replacements in a Potent Series of VEGFR-2 Inhibitors and Their Impact on Potency, Solubility, and hERG
Mainolfi, Nello
Powers, James
Meredith, Erik
Elliott, Jason
Gunderson, Karl G.
Poor, Stephen
Liu, Fang
Anderson, Karen
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (04): : 357 - 362
[47] Identification of Novel Potential VEGFR-2 Inhibitors Using a Combination of Computational Methods for Drug Discovery
Al-Sanea, Mohammad M.
Chilingaryan, Garri
Abelyan, Narek
Sargsyan, Arsen
Hovhannisyan, Sargis
Gasparyan, Hayk
Gevorgyan, Smbat
Albogami, Sarah
Ghoneim, Mohammed M.
Farag, Ahmed K.
Mohamed, Ahmed A. B.
El-Damasy, Ashraf K.
LIFE-BASEL, 2021, 11 (10):
[48] Xanthatin, a novel potent inhibitor of VEGFR2 signaling, inhibits angiogenesis and tumor growth in breast cancer cells
Yu, Yao
Yu, Jing
Pei, Chong Gang
Li, Yun Yan
Tu, Ping
Gao, Gui Ping
Shao, Yi
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (09): : 10355 - 10364
[49] Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents
El-Metwally, Souad A.
Abou-El-Regal, Mohsen M.
Eissa, Ibrahim H.
Mehany, Ahmed B. M.
Mahdy, Hazem A.
Elkady, Hazem
Elwan, Alaa
Elkaeed, Eslam B.
BIOORGANIC CHEMISTRY, 2021, 112
[50] Discovering novel 7-azaindole-based series as potent AXL kinase inhibitors
Feneyrolles, Clemence
Guiet, Lea
Singer, Mathilde
Van Hijfte, Nathalie
Dayde-Cazals, Benedicte
Fauvel, Benedicte
Cheve, Gwenael
Yasri, Abdelaziz
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (04) : 862 - 866

← 1 2 3 4 5 →